Prosecution Insights
Last updated: August 06, 2026

Xiamen University

9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (78%)
0
Medium (0%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (11%)
§101 + other1 (11%)
§112 only2 (22%)
Multi-statute (no §101)5 (56%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
89% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
11% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WANG, RUIXUE 1 57.4% +22.1%
POLLOCK, AUSTIN M 1 51.7% +36.5%
NIEBAUER, RONALD T 1 41.0% +33.6%
BAUER, NICOLA MARIA 1 56.6% +47.4%
REYNOLDS, FRED H 1 33.1% +39.0%
SIMMONS, VALERIE MICHELLE 1 30.2% +50.5%
MONTES, NARCISO EDUARDO 1 57.1% +0.0%
KINSEY WHITE, NICOLE ERIN 1 58.0% +16.2%
GIAMMONA, FRANCESCA FILIPPA 1 37.0% +55.9%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18350803 PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES NIEBAUER, RONALD T 60d
18292538 GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF WANG, RUIXUE
18449932 COMPOSITE METAL MATERIAL AND LOW-TEMPERATURE SOLDER PASTE WITH HIGH THERMAL CONDUCTIVITY CONTAINING SAME POLLOCK, AUSTIN M
18349434 TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF BAUER, NICOLA MARIA
18143920 METHOD FOR TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE DIFFUSION ORDERED SPECTROSCOPY BASED ON DEEP LEARNING MONTES, NARCISO EDUARDO
17997465 DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD KINSEY WHITE, NICOLE ERIN
17757986 METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID GIAMMONA, FRANCESCA FILIPPA

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18350803 PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES NIEBAUER, RONALD T 60d
18337091 PREPAKAGED POLYMERASE CHAIN REACTION (PCR) REAGENT FOR NUCLEIC ACID AMPLIFICATION AND METHOD THEREOF REYNOLDS, FRED H 70d
18267586 FLUORESCENCE ANALYSIS METHOD FOR LITHIUM ION DETERMINATION USING FREE-BASE PHTHALOCYANINE (FBPc) AS MOLECULAR PROBE SIMMONS, VALERIE MICHELLE 71d
18292538 GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF WANG, RUIXUE
18449932 COMPOSITE METAL MATERIAL AND LOW-TEMPERATURE SOLDER PASTE WITH HIGH THERMAL CONDUCTIVITY CONTAINING SAME POLLOCK, AUSTIN M
18349434 TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF BAUER, NICOLA MARIA
17997465 DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD KINSEY WHITE, NICOLE ERIN
17757986 METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID GIAMMONA, FRANCESCA FILIPPA

Top Art Units

Art UnitApps
1672 2
1658 2
1738 1
1621 1
1758 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18292538 GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF WANG, RUIXUE 1672 §103§112 Non-Final OA Pending Jan 26, 2024
18449932 COMPOSITE METAL MATERIAL AND LOW-TEMPERATURE SOLDER PASTE WITH HIGH THERMAL CONDUCTIVITY CONTAINING SAME POLLOCK, AUSTIN M 1738 §102§103 Final Rejection Pending Aug 15, 2023
18350803 PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES NIEBAUER, RONALD T 1658 §101§102§112 Non-Final OA 60d Pending Jul 12, 2023
18349434 TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF BAUER, NICOLA MARIA 1621 §103§112 Non-Final OA Pending Jul 10, 2023
18337091 PREPAKAGED POLYMERASE CHAIN REACTION (PCR) REAGENT FOR NUCLEIC ACID AMPLIFICATION AND METHOD THEREOF REYNOLDS, FRED H 1658 §112 Final Rejection 70d Pending Jun 19, 2023
18267586 FLUORESCENCE ANALYSIS METHOD FOR LITHIUM ION DETERMINATION USING FREE-BASE PHTHALOCYANINE (FBPc) AS MOLECULAR PROBE SIMMONS, VALERIE MICHELLE 1758 §112 Non-Final OA 71d Pending Jun 15, 2023
18143920 METHOD FOR TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE DIFFUSION ORDERED SPECTROSCOPY BASED ON DEEP LEARNING MONTES, NARCISO EDUARDO §101 Non-Final OA Pending May 05, 2023
17997465 DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD KINSEY WHITE, NICOLE ERIN 1672 §103§112 Final Rejection Pending Oct 28, 2022
17757986 METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID GIAMMONA, FRANCESCA FILIPPA 1681 §102§103 Non-Final OA Pending Jun 24, 2022

Managing Xiamen University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month